City Therapeutics, Inc. (CTY)
NASDAQ: CTY · Real-Time Price · USD
18.10
-0.88 (-4.64%)
At close: Nov 13, 2026, 4:00 PM EST
18.45
+0.35 (1.93%)
After-hours: Nov 13, 2026, 7:30 PM EST
City Therapeutics Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, City Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $37.33. The average 1-year stock price forecast is 106.24% higher than the current stock price, while the lowest is $32 (+76.80%) and the highest is $46 (+154.14%).
Price Target: $37.33 (+106.24%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for City Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Initiates $32 | Buy | Initiates | $32 | +76.80% | Nov 10, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Initiates $34 | Buy | Initiates | $34 | +87.85% | Nov 10, 2026 |
Financial Forecast
Revenue This Year
22.10M
from 13.56M
Increased by 62.96%
Revenue Next Year
23.75M
from 22.10M
Increased by 7.47%
EPS This Year
-4.04
EPS Next Year
-3.03
from -4.04
EPS and Forward PE are based on non-GAAP adjusted numbers.